Omarol Tablet 12.5 mg contains Omarigliptin, a modern oral antidiabetic medication belonging to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Omarigliptin helps manage type 2 diabetes mellitus by enhancing the body’s natural ability to regulate blood glucose. It works by inhibiting the enzyme DPP-4, which leads to increased levels of incretin hormones such as GLP-1 and GIP. These hormones stimulate insulin secretion in response to meals and reduce the production of glucagon, a hormone that raises blood glucose.
Omarol is unique because of its once-weekly dosing, offering convenience and improving adherence compared to daily antidiabetic medications. It is particularly suitable for adults with type 2 diabetes who require better glycemic control alongside diet and exercise.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Omarol Tablet 12.5 mg is indicated for:
Type 2 diabetes mellitus: As monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin when diet and exercise alone are insufficient.
Glycemic control: Helps reduce fasting and postprandial blood glucose levels.
Adjunct therapy: For patients needing a convenient, once-weekly oral medication to maintain stable blood sugar levels.
It is not indicated for type 1 diabetes or diabetic ketoacidosis.
Once-weekly dosing: Enhances patient adherence and convenience compared to daily oral medications.
Improves glycemic control: Reduces fasting and postprandial blood sugar levels effectively.
Supports natural insulin response: Stimulates insulin secretion in a glucose-dependent manner, minimizing risk of hypoglycemia when used alone.
Reduces glucagon secretion: Helps prevent excessive glucose production by the liver.
Well-tolerated: Generally safe with a low risk of significant side effects.
Omarol 12.5 mg provides a modern, patient-friendly approach to managing type 2 diabetes with effective blood sugar control.
The standard recommended dose is 12.5 mg once weekly, preferably on the same day each week.
Swallow the tablet whole with water, with or without food.
Regular monitoring of blood glucose levels is recommended to assess treatment efficacy.
Continue following a diabetic diet, exercise plan, and lifestyle modifications to maximize the benefits of therapy.
Dose adjustments may be needed for patients with moderate to severe kidney impairment; consult a physician for personalized guidance.
Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.
Use caution in patients with renal impairment; dose adjustments may be necessary.
Inform your doctor about all medications being taken to avoid potential interactions, especially with other antidiabetic drugs.
Monitor for signs of hypoglycemia if used with insulin or sulfonylureas.
Not recommended during pregnancy or breastfeeding unless prescribed and monitored by a healthcare professional.
Omarol Tablet 12.5 mg is generally well tolerated. Common side effects may include:
Nasopharyngitis or mild respiratory infections
Headache
Gastrointestinal discomfort such as nausea or diarrhea
Rare cases of hypoglycemia when combined with insulin or sulfonylureas
Severe but rare side effects may include allergic reactions or pancreatitis. Immediate medical attention is required if severe symptoms occur.
Store below 25°C in a cool, dry place.
Protect from moisture, light, and heat.
Keep out of reach of children.
Do not use after the expiration date printed on the packaging.
Omarol Tablet 12.5 mg (Omarigliptin) offers an effective and convenient once-weekly solution for adults with type 2 diabetes. It helps improve glycemic control, supports natural insulin response, and reduces the risk of complications associated with poorly managed blood sugar.
Login Or Registerto submit your questions to seller
No none asked to seller yet